Home > E. Pathology by systems > Endocrine system > Adrenals > adrenal cortical carcinoma
adrenal cortical carcinoma
Tuesday 16 March 2004
adrenal cortical carcinomas; adrenocortical carcinoma
Images
Adrenal cortical adenoma and carcinoma
Digital cases
JRC:14921 : Lung metastasis of adrenal cortical carcinoma.
JRC:14613 : Adrenal cortical carcinoma (with Cushing syndrome).
JRC:18771 : Adrenal cortical carcinoma
Grading systems / Microscopic prognostic parameters
Weiss score (2004) (21997290)
The reticulin algorithma (2013)
The Helsinski score (2015)
Differential diagnosis
islet cell carcinoma
pulmonary large cell undifferentiated carcinoma
hepatocellular carcinoma (HCC)
renal cell carcinoma
bronchogenic carcinoma
pheochromocytoma and paraganglioma
alveolar soft part sarcoma
Variants
oncocytic adrenocortical carcinoma
virilizing adrenocortical carcinoma
Immunochemistry
melan-A+ (MLANA+) (9422316)
alpha-inhibin+ (INHA+)
Predisposition
Beckwith-Wiedemann syndrome
germ-line P53 mutations
- Li-Fraumeni syndrome
- inherited R337H p53 mutation without Li-Fraumeni syndrome (11481490)
Carney complex
multiple endocrine neoplasia type 1
congenital adrenal hyperplasia
McCune-Albright syndrome
Associations
ganglioneuroblastoma (P53 germline mutations) (9598730)
Cytogenetics
CGH: 10514385
Molecular biology
> Multistep adrenocortical tumorigenesis (12629075)
TP53 (17p13)
- TP53 mutations (30-50%) (11454518)
- TP53-associated adrenocortical carcinoma
APC mutations
- APC-associated adrenocortical carcinoma
Locus 11p15.5
- LOH at 11p15.5 (28.5%)
- Uniparental disomy at 11p15.5 (24%) (7911125)
- IGF2 overexpression (10843195, 7911125)
- loss of function of p57KIP2 (10634406)
- Structural and functional abnormalities at 11p15 are associated with the malignant phenotype (9253334)
LOH at 11q13: significantly higher in adrenocortical carcinomas (60%) than in benign lesions (11%) (9935177)
high expression of cyclin E and G1 CDK
altered expression of novH (11502835)
allelotype: 9596277
CGH
Losses
1p21-31
2q
3p
3q
6q
9p
11q14-qter
Gains and amplifications
5q12
9q34
12q
17q
17p
20q
LOH
1p (22%)
3p (22%)
9p (26%)
References
The weiss score and beyond—histopathology for adrenocortical carcinoma. Papotti M, Libè R, Duregon E, Volante M, Bertherat J, Tissier F. Horm Cancer. 2011 Dec;2(6):333-40. PMID: 21997290
Reviews
Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults. Faria AM, Almeida MQ. Mol Cell Endocrinol. 2012 Mar 31;351(1):52-7. PMID: 22019901
Stratakis CA. Genetics of adrenocortical tumors: gatekeepers, landscapers and conductors in symphony. Trends Endocrinol Metab. 2003 Nov;14(9):404-10. PMID: 14580759
Reincke M, Beuschlein F, Slawik M, Borm K. Molecular adrenocortical tumourigenesis. Eur J Clin Invest. 2000 Dec;30 Suppl 3:63-8. PMID: 11281372